EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer
EZH2 通过其在乳腺癌中 PARP 介导的聚 ADP 核糖基化促进 PARP 抑制剂的反应
期刊:Oncogene
影响因子:6.9
doi:10.1038/onc.2017.311
H Yamaguchi, Y Du, K Nakai, M Ding, S-S Chang, J L Hsu, J Yao, Y Wei, L Nie, S Jiao, W-C Chang, C-H Chen, Y Yu, G N Hortobagyi, M-C Hung